UTC Investment
VC Fund
UTC Investment is a VC fund focused on Software and E-Commerce. UTC Investment is one of the leading private equity firms
- Total investments:
- 14
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries UTC Investment invests in
Stages UTC Investment invests in
Countries UTC Investment invests in
Round sizes
Round size
- Series A
- $1M–$14M
- Series B
- $6.3M–$14M
- Series C
- $6.8M–$15M
Investment Focus
Industry
- Software 3 (21%)
- E-Commerce 3 (21%)
- Biotechnology 3 (21%)
- Information Technology 3 (21%)
- Apps 2 (14%)
Stage
- Series B 6 (43%)
- Series A 4 (29%)
- Series C 3 (21%)
- Venture - Series Unknown 1 (7%)
Country
- South Korea 11 (79%)
- India 1 (7%)
- United States 1 (7%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| The White Communication provides cloud consulting, migration, and managed services for enterprises. The company designs architectures on public cloud platforms, sets up governance and security controls, and implements automation for deployment and operations. Service offerings include workload assessment, application containerization, CI/CDenablement, monitoring, backup, and disaster recovery planning. Cost management support covers rightsizing, billing visibility, and usage optimization. Integration work connects cloud infrastructure with identity management, networking, and data services. Training and documentation help client teams operate and scale environments after handoff. | $6.9M / Venture - Series Unknown / Feb 18, 2025 | ||
| Humanscape is a rare disease health-tech company working to bring better chances of cure for patients. By collecting comprehensive patient health data from genotype, clinical to phenotype data and systematically compiling it into a complete, ready-to-use data set, pharmaceuticals and researchers can significantly reduce both time and cost for newdrug development. | $14.9M / Series C / May 12, 2023 | ||
| Genecker develops genetic analysis technologies aimed at enabling the early detection and personalized management of cancer and genetic disorders. The company offers genome analysis services for oncology, prenatal screening, rare diseases, and individual health assessments, providing healthcare professionals and individuals with accurate andcost-effective diagnostic insights to support informed clinical decision-making. | $6.6M / Series B / Apr 01, 2022 | ||
| Curi Bio is a biotechnology company that focuses on advancing drug discovery and development through innovative approaches involving human stem cells, systems biology, and data analytics. The company's primary goal is to accelerate the process of identifying and developing new medicines.Curi Bio's platform revolves around the use ofhuman stem cells, which have the potential to be differentiated into various cell types, replicating the behavior of different tissues and organs. This allows researchers to create more accurate and relevant models for studying disease mechanisms and testing potential drug candidates.NanoSurface Biomedical Is Now Curi Bio. | $10M / Series A / Dec 29, 2021 | ||
| S.LAB is a platform for supply chain logistics for an efficient and cost-saving end to end transportation service. Through its cold chain technology, the company significantly reduces the cost during the first mile and middle mile delivery. Real-time tracking service will collect all the data to actively respond to the incident and keep thecustomer satisfied. With the data, S.LAB optimizes the temperature, packaging, and routing to increase the efficiency in cold chain delivery per country. | $12.6M / Series B / Dec 28, 2021 | ||
| Norma is a computer network security company that offers cyber asset security and information asset security consulting services. | $9.6M / Series C / Aug 06, 2021 | ||
| WEFUN management B2B welfare services. Snack24 provides office snack management services. | $6.3M / Series B / Apr 01, 2021 | ||
| The Mamma is a life omni-platform company that delivers the freshest food ingredients from local marts to customers. | $11.2M / Series B / Feb 05, 2021 | ||
| Mommaeat is a Korea based O2O shopping mart. | $13.5M / Series B / Feb 05, 2021 | ||
| NGeneBio provides in vitro diagnostics panel and clinical analysis software. | $10.6M / Series B / Nov 20, 2018 | ||
| See all 14 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does UTC Investment invest in?
UTC Investment invests primarily in Software, E-Commerce and Biotechnology startups, most often at Series B and Series A stage. Most of the 14 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does UTC Investment invest in?
UTC Investment typically joins rounds of $1M–$14M at Series A, $6.3M–$14M at Series B and $6.8M–$15M at Series C. These are whole funding-round sizes, not UTC Investment's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds UTC Investment took part in.
When did UTC Investment last invest?
The most recent investment recorded for UTC Investment closed in Feb 2025. Shizune tracks 14 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Nov 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
